Latest News
Orchard Funding Group reports in-line trading
Orchard Funding Group reports trading in-line with directors' expectations for the six months ending 31 January.
US pre-open: Equities to nudge higher ahead of Fed announcement
US stocks looked set to nudge higher at the open on Wednesday as investors looked to the latest policy announcement by the Federal Reserve.
Mobile Streams' shares tumble on FY profit warning
Shares in Mobile Streams are down more than 10% after it warned challenges in its Argentina operations will see the company's full-year revenue and EBITDA materially below market expectations.
Jayal to lead Quixant as Jarmany undergoes medical treatment
Gaming industry technology provider Quixant announced on Wednesday that CEO Nick Jarmany would, for the duration of medical treatment he required, pass on his executive responsibilities to chief operating officer Jon Jayal.
Europe open: Oil stocks bounce on surprise remarks from Saudi officials
European stocks began the morning on the frontfoot after surprise remarks from Saudi's energy minister overnight reaffirming his support for oil market stability.
Macquarie upgrades Aldermore to 'outperform'
Macquarie has upgraded challenger bank Aldermore to ‘outperform’ from ‘neutral’.
UK unemployment rate improves but wage growth slows further
Unemployment levels in the UK fell to the lowest rate since the summer of 1975, but wage growth continued to slow and reinforce the sharp squeeze on consumers coming from rising inflation.
Scottish independence fervor at it highest level alongside strong euroscepticism
Support for Scottish independence is at its highest level ever recorded according to a survey, but it also revealed that the majority of Scots hold eurosceptic views.
Rising US oil stockpiles trigerred drop in Brent futures, IEA says
The recent drop in crude futures is mainly the result of a renewed build-up in US oil stockpiles amid a relentless ramp-up in OPEC's production in the run-up to its November output cut deal which was still feeding through the system, the rich world's energy watchdog said.
Canaccord upgrades Cape to 'buy'
Canaccord Genuity has upgraded Cape to ‘buy’ from ‘speculative buy’ and bumped up the price target to 250p from 230p given the reduction in the litigation risk and following the company’s full-year 2016 results on Wednesday.
London open: Stocks edge higher as investors eye jobs data, Fed
London stocks edged higher in early trade and the pound bounced back from losses as investors awaited the release of key UK jobs data and looked to the Federal Reserve’s latest policy announcement.
Leaked Trump tax returns show millions paid via tax law he wants to abandon
US President Donald Trump was forced to pay over $30m in 2005 in federal taxes based on legislation brought in to ensure the mega-rich paid more to the state, a leaked tax return shows.
StatPro swings to statutory loss while recurring revenue improves
Cloud-based asset management portfolio analysis and asset pricing service provider StatPro Group announced its unaudited preliminary results for the year to 31 December on Wednesday, with revenue rising 25% to £37. 55m or 16% at constant currencies.
Cape full-year profit up 6% despite challenging backdrop
Cape reported a 6% jump in full-year profit as it expressed confidence over its prospects for 2017.
Sports Direct cries 'fake news' at PIRC pay criticism
In a manner akin to a Donald Trump tweet, Sports Direct International has dismissed as "fake news" a critical report about its pay structure from an influential corporate governance body.
Babcock lifted by Liberum upgrade
Engineering support and outsourcing company Babcock got a boost on Wednesday as Liberum upgraded its stance on the stock to ‘buy’ from ‘hold’, maintaining its 960p price target.
Robert Walters posts record full-year profit
Recruiter Robert Walters reported a 26% rise in full-year pre-tax profit as revenue grew and net fee income increased across all of the group's regions and 15 countries delivered record performances.
AstraZeneca ovarian cancer drug trial shows 'significant improvement'
AstraZeneca said results from the phase 3 trial of its ovarian cancer treatment Lynparza had demonstrated a “significant improvement in progression-free survival” (PFS).
Playtech founder offloads £113m of shares
Playtech founder Teddy Sagi is to sell £113m of shares in the gambling software company to London-based hedge fund Boussard & Gavaudan.
LondonMetric Property sells more retail parks to focus on logistics
FTSE 250 logistics investor LondonMetric Property has sold three retail parks in Christchurch, Bedford and Maidstone for a collected £60. 9m.